Skip to content
10-K

Annual Report

ASSEMBLY BIOSCIENCES, INC. ASMB

0001193125-26-115992

← back to feed
Filed
Mar 19, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 13, 2026 15.86M sh
Shares Diluted FY 2025 · Dec 31, 2025 11.21M sh
Shares Diluted FY 2025 · Dec 31, 2024 6M sh
Capex FY 2025 · Dec 31, 2025 $66K
Capex FY 2025 · Dec 31, 2024 $28K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$41.09M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$51.12M
Cash And Equivalents FY 2025 · Dec 31, 2025 $58.45M
Cash And Equivalents FY 2025 · Dec 31, 2024 $38.34M
Stockholders Equity FY 2025 · Dec 31, 2025 $206.75M
Stockholders Equity FY 2025 · Dec 31, 2024 $33.36M
Stockholders Equity FY 2025 · Dec 31, 2023 $41.1M
Current Liabilities FY 2025 · Dec 31, 2025 $48.78M
Current Liabilities FY 2025 · Dec 31, 2024 $47.8M
Total Liabilities FY 2025 · Dec 31, 2025 $50.84M
Total Liabilities FY 2025 · Dec 31, 2024 $85.81M
Current Assets FY 2025 · Dec 31, 2025 $254.55M
Current Assets FY 2025 · Dec 31, 2024 $115.5M
Total Assets FY 2025 · Dec 31, 2025 $257.59M
Total Assets FY 2025 · Dec 31, 2024 $119.17M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.55
Eps Diluted FY 2025 · Dec 31, 2024 −$6.69
Eps Basic FY 2025 · Dec 31, 2025 −$0.55
Eps Basic FY 2025 · Dec 31, 2024 −$6.69
Sga Expense FY 2025 · Dec 31, 2025 $19.61M
Sga Expense FY 2025 · Dec 31, 2024 $18.01M
Rd Expense FY 2025 · Dec 31, 2025 $64.81M
Rd Expense FY 2025 · Dec 31, 2024 $55.93M
Net Income FY 2025 · Dec 31, 2025 −$6.12M
Net Income FY 2025 · Dec 31, 2024 −$40.18M
Operating Income FY 2025 · Dec 31, 2025 −$12.12M
Operating Income FY 2025 · Dec 31, 2024 −$45.42M
Revenue FY 2025 · Dec 31, 2025 $72.3M
Revenue FY 2025 · Dec 31, 2024 $28.52M